Biosynthesis of zinc oxide nanoparticles from actinomycetes and its therapeutic applications

This groundbreaking study delves into the biosynthesis of zinc oxide nanoparticles (ZnO NPs) utilizing actinomycetes isolated from soil, shedding light on their remarkable therapeutic potential. Through meticulous screening and optimization, actinomycete strains were identified as efficient producers of ZnO NPs, yielding particles ranging from 70-90 nm in size. Advanced characterization techniques, including scanning electron microscopy (SEM), UV-Visible spectroscopy, and Fourier transform infrared (FTIR) spectroscopy, confirmed the nanoparticles' size and structure. The biosynthesized ZnO NPs demonstrated profound antibacterial activity against multidrug-resistant pathogens, highlighting their promise in combating antimicrobial resistance. This eco-friendly and cost-effective biosynthesis approach presents a sustainable alternative to chemical methods, paving the way for future developments in nanomedicine. By harnessing the potential of actinomycetes, this research offers a viable solution for addressing the growing concern of antimicrobial resistance and advancing healthcare. The therapeutic applications of ZnO NPs are vast, with potential uses in wound healing, targeted drug delivery, cancer therapy, and biosensors. This study validates actinomycete-mediated ZnO NPs biosynthesis as a groundbreaking approach, opening new avenues for nanomedicine innovation. As the world grapples with the challenges of antimicrobial resistance, this research provides a beacon of hope for the development of novel, effective, and sustainable treatments.